Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Sensation Disorders: full-pipeline trial registry

5 of 7 indexed Sensation Disorders trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Sensation Disorders: 7 US clinical trials tracked, 5 recruiting.

Sensation Disorders is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 4 of these trials.

Enrollment posture brief

Registry condition sensation-disorders

OPEN 5 | RECR 71% | LATE 1 | EARLY 1 | RANK #2497 | SPON 4

Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)

ACL Tear71.4%Sensation Disorders (this)71%ACL57.1%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Sensation Disorders

Sensation Disorders lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sensation Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sensation Disorders is recruiting above its size-band peers.

    5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Sensation Disorders research.

    Johns Hopkins University accounts for 4 of 7 trials (57.1%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Sensation Disorders trials plan to enrol fewer than 100 people.

    Median target enrolment is 32 among the 7 trials that report a genuine target (sentinel values excluded). 6 of those (85.7%) plan for fewer than 100 participants.

  4. Sensation Disorders research is mostly interventional.

    6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 31

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1

Named interventions

Most-linked intervention names on Sensation Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Labyrinth Devices MVI™ Multichannel Vestibular Implant System Device
3 trials
sepofarsen Drug
2 trials
Labyrinth Devices MVI™ Multichannel Vestibular Implant Device
1 trials
Sensory testing Diagnostic test
1 trials
Sham Other
1 trials
Placebo IVT Other
1 trials

US sites by state

Facility locations filed on Sensation Disorders trials. A trial with sites in several states counts in each.

Maryland 4 trials
Iowa 2 trials
Pennsylvania 1 trials
New York 1 trials
Minnesota 1 trials
Massachusetts 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sensation Disorders page

7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sensation Disorders condition card totals 7 registered trials; most-linked intervention Labyrinth Devices MVI™ Multichannel Vestibular Implant System; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.